bibliographicCitation |
Schallier D, Decoster L, Braeckman J, Fontaine C, Degrève J. Docetaxel in the treatment of metastatic castration-resistant prostate cancer (mCRPC): an observational study in a single institution. Anticancer Res. 2012 Feb;32(2):633–41. PMID: 22287756. |